Condition
Gastric Cancer, Gastroesophageal Junction Cancer clinical trials and research
Research outlook What's coming for Stomach cancer: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 4 Gastric Cancer, Gastroesophageal Junction Cancer clinical trials that are recruiting, in China. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 1Country
Newest Gastric Cancer, Gastroesophageal Junction Cancer clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Robotic versus laparoscopic radical surgery for locally advanced stomach and gastroesophageal junction cancer | — | Chongqing, Chongqing Municipality and 1 other locations | Recruiting | Jan 24, 2025 |
| Exploring how psychological stress affects treatment outcomes in gastric cancer | — | Shanghai, Shanghai Municipality | Recruiting | Jan 22, 2025 |
| Treatment of locally advanced gastric cancer with Tislelizumab and chemotherapy | — | Chongqing, Chongqing Municipality and 1 other locations | Recruiting | Jan 7, 2025 |
| Predicting treatment response in gastric cancer using immune markers | — | Xuhui District, Shanghai Municipality | Recruiting | Oct 28, 2024 |
All recruiting trials (4)
-
Robotic versus laparoscopic radical surgery for locally advanced stomach and gastroesophageal junction cancer
This trial will test whether robotic gastrectomy is as effective as — and safer than — laparoscopic gastrectomy for adults aged 18–74 with locally advanced stomach or gastroesophageal junction cancer.
-
Exploring how psychological stress affects treatment outcomes in gastric cancer
This study is trying to see how psychological stress affects the treatment results for people with gastric cancer who have had surgery and other therapies.
-
Treatment of locally advanced gastric cancer with Tislelizumab and chemotherapy
This study is testing if a new treatment combining Tislelizumab and chemotherapy can help people with locally advanced gastric cancer live longer and have fewer problems after treatment.
-
Predicting treatment response in gastric cancer using immune markers
This study is trying to find out if certain immune markers in the blood can help doctors predict how well advanced gastric cancer patients will respond to chemotherapy and immunotherapy.
Related topics
Quick answers
How many Gastric Cancer, Gastroesophageal Junction Cancer clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.